Skip to main content
Signal8
Taglietti Marco profile photo

Marco Taglietti

CIK: 0001408870

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Aquestive Therapeutics, Inc. logo
AQST

Aquestive Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Jun 10, 2026
    Award(A)

    Stock Option (Right to Purchase)

    Direct
    50.5K shares-
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Jun 11, 2025
    Award(A)

    Stock Option (Right to Purchase)

    Direct
    42K shares at avg. $3.41-

1-2 of 2

About Taglietti Marco

Taglietti Marco (SEC CIK 0001408870) files insider reports with the SEC as Director of Aquestive Therapeutics, Inc. (AQST).

Signal8 holds 2 ownership filings by Taglietti Marco, all Form 4s, filed between Jun 12, 2025 and Jun 12, 2026. Those filings report 2 transactions, from Jun 11, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Taglietti Marco's filings is in WARREN, NJ.

Recent filings by Taglietti Marco

  • Jun 10, 2026: Grant or award of AQST derivative securities (Form 4, code A).
  • Jun 11, 2025: Grant or award of AQST derivative securities (Form 4, code A).

Other insiders filing for Aquestive Therapeutics, Inc. (AQST)

How to read Form 4 transaction codes